β-thalassemias

Loading...
Thumbnail Image

Date

Journal Title

Journal ISSN

Volume Title

Publisher

Massachussetts Medical Society

Abstract

Description

Keywords

Activin receptors, type ii, Beta-thalassemia, Erythrocyte transfusion, Genetic therapy, Genotype, Hematinics, Hematopoietic stem cell transplantation, Humans, Immunoglobulin fc fragments, Iron overload, Phenotype, Recombinant fusion proteins, Creatinine, Deferasirox, Deferiprone, Deferoxamine, Hemoglobin, Liver enzyme, Luspatercept, Placebo, Activin receptor 2, Antianemic agent, Fusion protein, Immunoglobulin fc fragment, Agranulocytosis, Arthralgia, Beta thalassemia, Blood transfusion, Bone disease, Bone pain, Clinical feature, Dizziness, Dna determination, Drug hypersensitivity, Ear disease, Eye disease, Family history, Gastrointestinal symptom, Gene therapy, Genotype phenotype correlation, Geographic distribution, Hemoglobin synthesis, Human, Hypertension, Hyperuricemia, Iron chelation, Medical history, Molecular pathology, Neutropenia, Nonhuman, Patient care, Physical examination, Psychosocial care, Review, Side effect, Thrombosis, Adverse event, Complication, Genetics

Citation

Endorsement

Review

Supplemented By

Referenced By